Sequencing of TGF-β pathway genes in familial cases of intracranial aneurysm

Stroke

Volumn 40, Issue 5, 2009, Pages 1604-1611

  Santiago Sim, Teresa ^a   Mathew Joseph, Sumy ^a   Pannu, Hariyadarshi ^b   Milewicz, Dianna M ^b   Seidman, Christine E ^a,d   Seidman, J G ^a   Kim, Dong H ^b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Aneurysm; Betaglycan; Endoglin; TGFBR1, TGFBR2

Indexed keywords

ENDOGLIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3; TRANSFORMING GROWTH FACTOR BETA1; ACTIVIN RECEPTOR 1; ACVR1 PROTEIN, HUMAN; CELL SURFACE RECEPTOR; DNA; ENG PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; PRIMER DNA; PROTEIN SERINE THREONINE KINASE; PROTEOGLYCAN; TGF BETA TYPE I RECEPTOR; TGF-BETA TYPE I RECEPTOR; TRANSFORMING GROWTH FACTOR BETA TYPE II RECEPTOR; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; INTRACRANIAL ANEURYSM; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; ALLELE; GENETICS; MIDDLE AGED; PEDIGREE; SIGNAL TRANSDUCTION; STROKE;

ACTIVIN RECEPTORS, TYPE I; AGED; ALLELES; ANTIGENS, CD; DNA; DNA PRIMERS; FEMALE; HUMANS; INTRACRANIAL ANEURYSM; MALE; MIDDLE AGED; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; PROTEOGLYCANS; RECEPTORS, CELL SURFACE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; STROKE; TRANSFORMING GROWTH FACTOR BETA;

EID: 65549144871     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.540245     Document Type: Article

References (35)

1. Ruigrok YM, Rinkel GJ. Genetics of intracranial aneurysms. Stroke. 2008;39:1049-1055.
2. Kim DH, Van Ginhoven G, Milewicz DM. Incidence of familial intra-cranial aneurysms in 200 patients: Comparison among Caucasian, African-American, and Hispanic populations. Neurosurgery. 2003;53: 302-308.
3. Wills S, Ronkainen A, van der Voet M, Kuivaniemi H, Helin K, Leinonen E, Frosen J, Niemela M, Jaaskelainen J, Hernesniemi J, Tromp G. Familial intracranial aneurysms: An analysis of 346 multiplex Finnish families. Stroke. 2003;34:1370-1374.
4. Ronkainen A, Hernesniemi J, Ryynanen M. Familial subarachnoid hemorrhage in east Finland, 1977-1990. Neurosurgery. 33:787-796, 1993; discussion 796-797.
5. Kojima M, Nagasawa S, Lee YE, Takeichi Y, Tsuda E, Mabuchi N. Asymptomatic familial cerebral aneurysms. Neurosurgery. 1998;43: 776-781.
6. Bromberg JE, Rinkel GJ, Algra A, Greebe P, van Duyn CM, Hasan D, Limburg M, ter Berg HW, Wijdicks EF, van Gijn J. Subarachnoid haemorrhage in first and second degree relatives of patients with sub-arachnoid haemorrhage. Bmj. 1995;311:288-289.
7. Nakajima H, Kishi H, Yasui T, Komiyama M, Iwai Y, Yamanaka K, Nishikawa M. Intracranial aneurysms in identical twins. Surg Neurol. 1998;49:306-308.
8. Schievink WI, Schaid DJ, Rogers HM, Piepgras DG, Michels VV. On the inheritance of intracranial aneurysms. Stroke. 1994;25:2028-2037.
9. Kim DH, Van Ginhoven G, Milewicz DM. Familial aggregation of both aortic and cerebral aneurysms: Evidence for a common genetic basis in a subset of families. Neurosurgery. 56:655-661, 2005; discussion 655-661.
10. Milewicz DM, Chen H, Park ES, Petty EM, Zaghi H, Shashidhar G, Willing M, Patel V. Reduced penetrance and variable expressivity of familial thoracic aortic aneurysms/dissections. Am J Cardiol. 1998;82: 474-479.
11. Norrgard O, Angqvist KA, Fodstad H, Forssell A, Lindberg M. Co-existence of abdominal aortic aneurysms and intracranial aneurysms. Acta Neurochir (Wien). 1987;87:34-39.
12. Barbour JR, Spinale FG, Ikonomidis JS. Proteinase systems and thoracic aortic aneurysm progression. J Surg Res. 2007;139:292-307.
13. Bruno G, Todor R, Lewis I, Chyatte D. Vascular extracellular matrix remodeling in cerebral aneurysms. J Neurosurg. 1998;89:431-440.
14. Hara A, Yoshimi N, Mori H. Evidence for apoptosis in human intracranial aneurysms. Neurol Res. 1998;20:127-130.
15. Thompson RW, Liao S, Curci JA. Vascular smooth muscle cell apoptosis in abdominal aortic aneurysms. Coron Artery Dis. 1997;8:623-631.
16. Chyatte D, Bruno G, Desai S, Todor DR. Inflammation and intracranial aneurysms. Neurosurgery. 45:1137-1146, 1999; discussion 1146-1137.
17. He R, Guo DC, Estrera AL, Safi HJ, Huynh TT, Yin Z, Cao SN, Lin J, Kurian T, Buja LM, Geng YJ, Milewicz DM. Characterization of the inflammatory and apoptotic cells in the aortas of patients with ascending thoracic aortic aneurysms and dissections. J Thorac Cardiovasc Surg. 2006;131:671-678.
18. Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H, De Backer JF, Oswald GL, Symoens S, Manouvrier S, Roberts AE, Faravelli F, Greco MA, Pyeritz RE, Milewicz DM, Coucke PJ, Cameron DE, Braverman AC, Byers PH, De Paepe AM, Dietz HC. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med. 2006;355:788-798.
19. Mizuguchi T, Collod-Beroud G, Akiyama T, Abifadel M, Harada N, Morisaki T, Allard D, Varret M, Claustres M, Morisaki H, Ihara M, Kinoshita A, Yoshiura K, Junien C, Kajii T, Jondeau G, Ohta T, Kishino T, Furukawa Y, Nakamura Y, Niikawa N, Boileau C, Matsumoto N. Heterozygous TGFBR2 mutations in Marfan syndrome. Nat Genet. 2004; 36:855-860.
20. Pannu H, Fadulu VT, Chang J, Lafont A, Hasham SN, Sparks E, Giampietro PF, Zaleski C, Estrera AL, Safi HJ, Shete S, Willing MC, Raman CS, Milewicz DM. Mutations in transforming growth factor-beta receptor type II cause familial thoracic aortic aneurysms and dissections. Circulation. 2005;112:513-520.
21. Singh KK, Rommel K, Mishra A, Karck M, Haverich A, Schmidtke J, Arslan-Kirchner M. TGFBR1 and TGFBR2 mutations in patients with features of Marfan syndrome and Loeys-Dietz syndrome. Hum Mutat. 2006;27:770-777.
22. Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, Myers L, Klein EC, Liu G, Calvi C, Podowski M, Neptune ER, Halushka MK, Bedja D, Gabrielson K, Rifkin DB, Carta L, Ramirez F, Huso DL, Dietz HC. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science. 2006;312:117-121.
23. Cohen MM Jr. TGF beta/SMAD signaling system and its pathologic correlates. Am J Med Genet A. 2003;116A:1-10.
24. Ignotz RA, Massague J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem. 1986;261:4337-4345.
25. Begbie ME, Wallace GM, Shovlin CL. Hereditary haemorrhagic telan-giectasia (Osler-Weber-Rendu syndrome): A view from the 21st century. Postgrad Med J. 2003;79:18-24.
26. Abdalla SA, Letarte M. Hereditary haemorrhagic telangiectasia: Current views on genetics and mechanisms of disease. J Med Genet. 2006;43: 97-110.
27. Kamiyama K, Okada H, Niizuma H, Higuchi H. [a case report: Osler-weber-rendu disease with cerebral aneurysm, cerebral arteriovenous malformation and pulmonary arteriovenous fistula (author's transl)]. No Shinkei Geka. 1981;9:67-72.
28. Compton LA, Potash DA, Brown CB, Barnett JV. Coronary vessel development is dependent on the type III transforming growth factor beta receptor. Circ Res. 2007;101:784-791.
29. Stenvers KL, Tursky ML, Harder KW, Kountouri N, Amatayakul-Chantler S, Grail D, Small C, Weinberg RA, Sizeland AM, Zhu HJ. Heart and liver defects and reduced transforming growth factor beta2 sensitivity in transforming growth factor beta type III receptor-deficient embryos. Mol Cell Biol. 2003;23:4371-4385.
30. Chand AL, Robertson DM, Shelling AN, Harrison CA. Mutational analysis of betaglycan/TGF-betarlll in premature ovarian failure. Fertil Steril. 2007;87:210-212.
31. Finger EC, Turley RS, Dong M, How T, Fields TA, Blobe GC. TbetarIII suppresses non-small cell lung cancer invasiveness and tumorigenicity. Carcinogenesis. 2008;29:528-535.
32. Takenaka K, Sakai H, Yamakawa H, Yoshimura S, Kumagai M, Nakashima S, Nozawa Y, Sakai N. Polymorphism of the endoglin gene in patients with intracranial saccular aneurysms. J Neurosurg. 1999;90: 935-938.
33. Krex D, Ziegler A, Schackert HK, Schackert G. Lack of association between endoglin intron 7 insertion polymorphism and intracranial an-eurysms in a white population: Evidence of racial/ethnic differences. Stroke. 2001;32:2689-2694.
34. Onda H, Kasuya H, Yoneyama T, Hori T, Nakajima T, Inoue I. Endoglin is not a major susceptibility gene for intracranial aneurysm among Japanese. Stroke. 2003;34:1640-1644.
35. Joo SP, Lee JK, Kim TS, Kim MK, Lee IK, Seo BR, Kim JH, Kim SH, Oh CW. A polymorphic variant of the endoglin gene is associated with increased risk for intracranial aneurysms in a korean population. Surg Neurol. 2008;70:39-44.